DanielKirschenbaum Deutsches Krebsforschungszentrum (DKFZ)Germany

Since 2025, Dr Kirschenbaum has been establishing his own research group at the DKFZ in Heidelberg. The aim is to gain a better understanding of the interaction between the immune system and cancer cells and to develop new approaches for treating patients. From 2005 to 2011, Dr Daniel Kirschenbaum studied human medicine at Semmelweis University in Budapest, where he graduated summa cum laude in 2011. He then began his specialist training in neurology (2011–2013) at the University Hospital of Tübingen, combined with clinical and scientific work at the Hertie Institute for Clinical Brain Research. From 2013, he continued his training as a resident at the Institute of Neuropathology at the University Hospital of Zurich, where he earned his medical doctorate in 2017 and received his specialist certification in diagnostic neuropathology in 2019. At the same time, he completed the doctoral program (MD PhD) at the University of Zurich between 2014 and 2019. His research work at the Institute of Neuropathology focused on new methods of tissue preparation and 3D imaging and led to his doctorate in 2019. From 2019 onwards, Dr Kirschenbaum worked as a specialist in neuropathology at the University Hospital of Zurich, where he specialised in the diagnosis of neurosurgical biopsies, muscular and cutaneous samples, and brain autopsies.